Adjuvant Metronomic CMF in a Contemporary Breast Cancer Cohort: What’s Old is New

Commonly used adjuvant systemic therapies harbor high rates of severe short-term and long-term side effects but are often justified to patients because of curative intent in early stage breast cancer. One of the oldest and least toxic adjuvant regimens, oral cyclophosphamide given with intravenous m...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Breast Cancer
Autors principals: Cho, Eunpi, Schwemm, Ann, Rubinstein, Lena, Stevenson, Phillip, Gooley, Ted A., Ellis, Georgiana, Specht, Jennifer M., Livingston, Robert B., Linden, Hannah M., Gadi, Vijayakrishna K.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4568144/
https://ncbi.nlm.nih.gov/pubmed/26025883
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clbc.2015.04.002
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars